Piramal Pharma aims to double turnover to $2 billion by 2030 – Times of India
Piramal Pharma aims to double its turnover to $2 bn by 2030, driven by its ``strategically- positioned’’ contract development and manufacturing organization (CDMO) business, and ``high-growth’’ verticals of complex hospital…